Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 2 24-2, 2001, Pages

  Kuwano, Kazuyoshi ^a,b   Kunitake, Ritsuko ^a   Maeyama, Takashige ^a   Hagimoto, Naoki ^a   Kawasaki, Masayuki ^a   Matsuba, Tokuji ^a   Yoshimi, Michihiro ^a   Inoshima, Ichiro ^a   Yoshida, Koichiro ^a   Kara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Lung injury

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BLEOMYCIN; CASPASE 3; CASPASE INHIBITOR; HYDROXYPROLINE; INTERLEUKIN 1BETA CONVERTING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG FIBROSIS; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 14344283933     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.2.l316     Document Type: Article

References (34)

1. Adamson IYR, Young L, and Bowden DH. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 130: 377-383, 1988.
2. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, and Casciola-Rosen L. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 8: 451-460, 1998.
3. Bardales RH, Xie S, Schaefer RF, and Hsu S. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 149: 845-852, 1996.
4. Braun JS, Novak R, Herzog KH, Bodner SM, Cleveland JL, and Tuomanen EI. Neuroprotection by a caspase inhibitor in a acute bacterial meningitis. Nat Med 5: 298-302, 1999.
5. Cheng Y, Desmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A, Sun Y, Jacquin MF, Johnson EM, and Holtzman DM. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neuronal hypoxic-ischemic brain injury. J Clin Invest 101: 1992-1999, 1998.
6. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, and Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med 310: 154-166, 1984.
7. Curio R, Gugenheim J, Rich JE, Crenesse D, Rostagno P, Mauron L, Saint-Paul MC, Ferrua B, and Auberger P. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 13: 253-261, 1999.
8. Daemen MARC, van't Veer C, Denecker G, Heemskerk VH, Wolfs TGAM, Clauss M, Vandenabeele P, and Buurman WA. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104: 541-549, 1999.
9. Gregoli PA and Bondurant MC. Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors. J Cell Physiol 178: 133-143, 1999.
10. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, and Su MS. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275: 206-209, 1997.
11. Guinee D, Fleming M, Hayashi T, Woodward M, Zhang J, Walls J, Koss M, Ferrans V, and Travis W. Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am J Pathol 149: 531-538, 1996.
12. Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, and Kara N. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 16: 91-101, 1997.
13. Harrison JH Jr, Hoyt DG, and Lazo JS. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice. Mol Pharmacol 36: 231-238, 1989.
14. Hudson LD, Milberg JA, Anardi D, and Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151: 293-301, 1995.
15. Krafft P, Friedrich P, Pernerstorfer T, Fitzgerald RD, Koc D, Schneider B, Hammerle AF, and Steltzer H. The acute respiratory distress syndrome: definitions, severity, and clinical outcome. An analysis of 101 clinical investigations. Intensive Care Med 22: 519-529, 1996.
16. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, and Flavell RA. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267: 2000-2003, 1995.
17. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kentaku R, Maeyama T, Miyazaki H, and Hara N. Essential roles of the Fas-Fas-ligand pathway in pulmonary fibrosis. J Clin Invest 104: 13-19, 1999.
18. Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 154: 477-483, 1996.
19. Li H, Zhu H, Xu CJ, and Yuan J. Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501, 1998.
20. Los M, van de Crean M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, and Schulza-Osthoff K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375: 81-83, 1995.
21. Luo X, Budihardjo I, Zou H, Slaughter C, and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1998.
22. Mao PL, Jiang Y, Wee BY, and Porter AG. Activation of caspase-1 in the nucleus requires nuclear translocation of procaspase-1 mediated by its prodomain. J Biol Chem 273: 23621-23624, 1998.
23. McColl KS, Huiling H, Hongying Z, Whitacre CM, Berger NA, and Distelhorst CW. Apoptosis induction by the glucocorticoid hormone dexamethasone and the calcium-ATPase inhibitor thapsigargin involves Bcl-2 regulated caspase activation. Mol Cell Endocrinol 139: 229-238, 1998.
24. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, and Suda T. Caspase-1 independent IL-β release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 4: 1287-1292, 1998.
25. Nakagawa A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su MSS, Zhao H, Cnaan A, and Sakiyama S. High levels of expression and nuclear localization of interleukin-1β converting enzyme (ICE) and CPP32 in favorable human neuroblastoma. Cancer Res 57: 4578-4584, 1997.
26. Omar T, Geraldine P, Belehradek J, and Luis M. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 53: 5462-5469, 1993.
27. Rodriguez I, Matsuura K, Ody C, Nagata S, and Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP-32 like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 184: 2067-2072, 1999.
28. Shi L, Chen G, Bergeron L, Li H, Miura M, Rotello RJ, Miller DK, Li P, Seshadri T, Yuan J, and Greenberg AH. Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B. Proc Natl Acad Sci USA 93: 11002-11007, 1996.
29. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, and Cohen GM. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274: 5053-5060, 1999.
30. Taoita H, Ogawa K, Maehara K, and Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97: 276-281, 1998.
31. Terzaghi M, Nettesheim P, and Williams ML. Re-population of denuded tracheal grafts with normal, pre-neoplastic and neoplastic epithelial cell populations. Cancer Res 38: 4546-4553, 1978.
32. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJF, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin TT, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, and Tocci MJ. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356: 768-774, 1992.
33. Tsutsui H, Kayagaki N, Kuida K, Nakano H, Hayashi N, Takeda K, Matsui K, Kashiwamura S, Hada T, Akira S, Yagita H, Okamura H, and Nakanishi K. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11: 359-367, 1999.
34. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93: 440-447, 1961.